Weill Cornell Medicine shared a post on LinkedIn:
“A new study using advanced laboratory technology reveals the inner workings of how a type of brain tumor progresses toward greater malignancy.
The research, led by Weill Cornell Medicine‘s Dr. Dan-Avi Landau, also of New York Genome Center, and colleagues at Harvard Medical School and Mass General Brigham, could inform the development of future treatments and prognostic measures for gliomas.
In this study, scientists applied advanced single-cell-profiling techniques and computational analysis tools – which they helped develop – to primary and recurrent tumor samples from patients with a form of glioma called IDH glioma.
They found that the cancer tends to become more aggressive due to an increasing tendency of the glioma cells to transform into immature, stem-cell-like states.
